Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

Documenti analoghi

• Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK/SIRT1/NLRP3 pathway
  di: Qiuxiao Zhu, et al.
  Pubblicazione: (2025-12-01)
• Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
  di: Kun‑Ling Tsai, et al.
  Pubblicazione: (2026-06-01)
• Ciprofol attenuates cerebral Ischemia‒reperfusion injury in rats by inhibiting ferroptosis through upregulating AMPK
  di: Hanyu Zeng, et al.
  Pubblicazione: (2026-02-01)
• Dapagliflozin ameliorates myocardial infarction injury through AMPKα-dependent regulation of oxidative stress and apoptosis
  di: Yuce Peng, et al.
  Pubblicazione: (2024-04-01)
• Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism
  di: Waad A. Samman, et al.
  Pubblicazione: (2023-05-01)